Tradewinds Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.9K Buy
677
+643
+1,891% +$34.9K 0.01% 279
2026
Q1
$2.13K Hold
34
﹤0.01% 550
2025
Q4
$3.24K Hold
34
﹤0.01% 489
2025
Q3
$3.32K Buy
34
+16
+89% +$1.66K ﹤0.01% 471
2025
Q2
$1.93K Hold
18
﹤0.01% 479
2025
Q1
$1.82K Sell
18
-40
-69% -$4.03K ﹤0.01% 489
2024
Q4
$5.18K Buy
58
+40
+222% +$3.52K ﹤0.01% 426
2024
Q3
$1.51K Sell
18
-25
-58% -$1.97K ﹤0.01% 490
2024
Q2
$3.31K Buy
43
+18
+72% +$1.32K ﹤0.01% 409
2024
Q1
$1.71K Hold
25
﹤0.01% 424
2023
Q4
$1.45K Buy
+25
New +$1.33K ﹤0.01% 369
2016
Q4
Sell
-300
Closed -$7K 638
2016
Q3
$7K Hold
300
﹤0.01% 406
2016
Q2
$7K Hold
300
0.01% 400
2016
Q1
$6K Hold
300
﹤0.01% 444
2015
Q4
$6K Hold
300
﹤0.01% 424
2015
Q3
$5K Hold
300
﹤0.01% 433
2015
Q2
$5K Hold
300
﹤0.01% 473
2015
Q1
$5K Hold
300
﹤0.01% 439
2014
Q4
$4K Hold
300
﹤0.01% 470
2014
Q3
$4K Hold
300
﹤0.01% 455
2014
Q2
$4K Hold
300
﹤0.01% 463
2014
Q1
$4K Hold
300
﹤0.01% 479
2013
Q4
$4K Buy
+300
New +$3.54K ﹤0.01% 453

Other funds holding BSX

Tradewinds Capital Management's BSX Position: Q2 2026 in Review

Tradewinds Capital Management increased its Boston Scientific (BSX) stake by 1,891% in Q2 2026, buying an estimated $34.9K and bringing the position to 677 shares worth $28.9K. The position accounts for 0.01% of the portfolio, ranked #279.

Tradewinds Capital Management first reported a position in BSX in Q4 2013 and has held it in 23 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Tradewinds Capital Management held 677 shares of Boston Scientific worth $28.9K as of Q2 2026.
  • Tradewinds Capital Management bought 643 Boston Scientific shares in Q2 2026, an estimated $34.9K.
  • Boston Scientific made up 0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #279 holding.
  • Tradewinds Capital Management first reported a position in Boston Scientific in Q4 2013 and has held it in 23 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.